BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papadakis KA, Targan SR. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:283-296. [PMID: 10372269 DOI: 10.1016/s0889-8553(05)70057-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease. World J Gastroenterol 2020; 26(5): 478-498 [PMID: 32089625 DOI: 10.3748/wjg.v26.i5.478] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alves VBF, de Sousa BC, Fonseca MTC, Ogata H, Caliári-Oliveira C, Yaochite JNU, Rodrigues Júnior V, Chica JEL, da Silva JS, Malmegrim KCR, Pernomian L, Cardoso CR. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.Clin Exp Immunol. 2019;196:139-154. [PMID: 30663040 DOI: 10.1111/cei.13262] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
3 Peiravan A, Bertolini F, Rothschild MF, Simpson KW, Jergens AE, Allenspach K, Werling D. Genome-wide association studies of inflammatory bowel disease in German shepherd dogs. PLoS One 2018;13:e0200685. [PMID: 30028859 DOI: 10.1371/journal.pone.0200685] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
4 Lu ZK, Chen ZR, Zhu JY, Xu Y, Hua X. Analysis of the association of single nucleotide polymorphisms of interleukin-23 receptor (IL-23R) and inflammatory bowel disease in a Chinese Han cohort. Oncotarget 2016;7:67851-6. [PMID: 27765927 DOI: 10.18632/oncotarget.12296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Li N, Shi RH. Updated review on immune factors in pathogenesis of Crohn’s disease. World J Gastroenterol 2018; 24(1): 15-22 [PMID: 29358878 DOI: 10.3748/wjg.v24.i1.15] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
6 Chiu CT, Kuo SN, Hung SW, Yang CY. Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid. Molecules 2017;22:E904. [PMID: 28556814 DOI: 10.3390/molecules22060904] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
7 Manhart A, Hellmann S, Hamelmann E, Schlarb AA. The association of sleep with inflammatory bowel disease in children and adolescents. Somnologie 2016;20:212-218. [DOI: 10.1007/s11818-016-0067-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Shi XZ, Winston JH, Sarna SK. Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2011;300:G41-51. [PMID: 20947704 DOI: 10.1152/ajpgi.00358.2010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
9 Zhong JP, Li DX, Li S, Li J, Xu J. Pentoxifylline suppresses the expression of tumor necrosis factor-α and interleukin-1β in ulcerative colitis in rats. Shijie Huaren Xiaohua Zazhi 2009; 17(36): 3679-3683 [DOI: 10.11569/wcjd.v17.i36.3679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chen JH, Wei SZ, Chen J, Wang Q, Liu HL, Gao XH, Li GC, Yu WZ, Chen M, Luo HS. Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci. 2009;54:1884-1891. [PMID: 19051028 DOI: 10.1007/s10620-008-0575-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Saruta M, Papadakis KA. Why are cytokines targeted for biological therapy in IBD?: . Inflammatory Bowel Diseases 2008;14:S121-2. [DOI: 10.1097/00054725-200810001-00059] [Reference Citation Analysis]
12 Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: Stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 2007; 13(22): 3027-3030 [PMID: 17589915 DOI: 10.3748/wjg.v13.i22.3027] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.0] [Reference Citation Analysis]
13 Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol 2007;102:820-8. [PMID: 17222320 DOI: 10.1111/j.1572-0241.2007.01045.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
14 Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 2007;52:1060-70. [PMID: 17342403 DOI: 10.1007/s10620-006-9124-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
15 Lee SK, Choi BK, Kim YH, Kang WJ, Kim KH, Sakaguchi S, Suh JH, Kim TY, Kwon BS. Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells. Immunology. 2006;119:479-487. [PMID: 17177830 DOI: 10.1111/j.1365-2567.2006.02459.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
16 Siddiqui A, Ancha H, Tedesco D, Lightfoot S, Stewart CA, Harty RF. Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis. Dig Dis Sci. 2006;51:698-705. [PMID: 16614991 DOI: 10.1007/s10620-006-3194-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
17 Ko JKS, Lam FYL, Cheung APL. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11(37): 5787-5794 [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
18 Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ. Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol 2005;100:1796-804. [PMID: 16086717 DOI: 10.1111/j.1572-0241.2005.50071.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
19 Stio M, Treves C, Martinesi M, d’Albasio G, Bagnoli S, Bonanomi AG. Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn’s disease. Dig Dis Sci. 2004;49:328-335. [PMID: 15104379 DOI: 10.1023/b:ddas.0000017460.90887.11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
20 Streutker CJ, Bernstein CN, Chan VL, Riddell RH, Croitoru K. Detection of species-specific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis. J Clin Microbiol. 2004;42:660-664. [PMID: 14766833 DOI: 10.1128/jcm.42.2.660-664.2004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
21 Dionne S, Laberge S, Deslandres C, Seidman EG. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin Exp Immunol 2003;133:108-14. [PMID: 12823284 DOI: 10.1046/j.1365-2249.2003.02191.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
22 Myles MH, Livingston RS, Livingston BA, Criley JM, Franklin CL. Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect Immun 2003;71:3885-93. [PMID: 12819073 DOI: 10.1128/IAI.71.7.3885-3893.2003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
23 Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2002;47:1447-1457. [PMID: 12141799 DOI: 10.1023/a:1015931128583] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 4.4] [Reference Citation Analysis]
24 Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, Baldassano RN. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol 2002;97:2005-10. [PMID: 12190168 DOI: 10.1111/j.1572-0241.2002.05915.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 161] [Article Influence: 7.4] [Reference Citation Analysis]
25 Burns RC, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Cominelli F, Ley K. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 2001;121:1428-36. [PMID: 11729122 DOI: 10.1053/gast.2001.29568] [Cited by in Crossref: 158] [Cited by in F6Publishing: 163] [Article Influence: 7.5] [Reference Citation Analysis]
26 Bousvaros A, Mueller B. Thalidomide in gastrointestinal disorders. Drugs. 2001;61:777-787. [PMID: 11398909 DOI: 10.2165/00003495-200161060-00006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
27 Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 2001;121:246-54. [PMID: 11487533 DOI: 10.1053/gast.2001.27154] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 7.7] [Reference Citation Analysis]
28 Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Kozaiwa K, Cominelli F. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest. 2001;107:695-702. [PMID: 11254669 DOI: 10.1172/jci10956] [Cited by in Crossref: 194] [Cited by in F6Publishing: 207] [Article Influence: 9.2] [Reference Citation Analysis]
29 Beyer PL. Nutrient Considerations in Inflammatory Bowel Disease and Short Bowel Syndrome. Nutrition in the Prevention and Treatment of Disease 2001. [DOI: 10.1016/b978-012193155-1/50040-4] [Reference Citation Analysis]
30 Béné M, Faure GC. Immunité innée et cognitive aux interfaces muqueuses. Revue Française des Laboratoires 2000;2000:49-55. [DOI: 10.1016/s0338-9898(00)80227-9] [Reference Citation Analysis]
31 Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 2000;119:1148-57. [PMID: 11040201 DOI: 10.1053/gast.2000.18160] [Cited by in Crossref: 254] [Cited by in F6Publishing: 274] [Article Influence: 11.5] [Reference Citation Analysis]
32 Rulyak SJ, Lichtenstein GR. A review of standard and novel therapies in Crohn’s disease. Expert Opinion on Therapeutic Patents 2000;10:1021-1033. [DOI: 10.1517/13543776.10.7.1021] [Reference Citation Analysis]